EUVIMEDEUVIMED entdecken
Crossref

PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models

Michael A Turner, Siamak Amirfakhri, Hiroto Nishino, Nicholas C Neel, Mojgan Hosseini, Kristin E Cox, Thinzar M Lwin, Lin Li, Teresa Hong, Anakim Sherman, John E Shively, Robert M Hoffman und 2 weitere

Journal of Surgical Research · 2023

DOI: 10.1016/j.jss.2023.06.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2023. Verfasst von Michael A Turner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, University of California San Diego, La Jolla, California; VA San Diego Healthcare System, La Jolla, Califo…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Colorectal cancer (CRC) patients often develop liver metastasis. However, curative resection of liver metastasis is not always possible due to poor visualization of tumor margins. The present study reports the characterization of a humanized anti-carcinoembryonic antigen monoclonal antibody conjugated to a PEGylated near-infrared dye, that targets and brightly labels human CRC tumors in metastatic orthotopic mouse models. METHODS: The hT84.66-M5A (M5A) monoclonal antibody was conjugated with a polyethylene glycol (PEG) chain that incorporated a near infrared (NIR) IR800 dye to establish M5A-IR800 Sidewinder (M5A-IR800-SW). Nude mice with CRC orthotopic primary tumors and liver metastasis both developed from a human CRC cell line, were injected with M5A-IR800-SW and imaged with the Pearl Trilogy Imaging System. RESULTS: M5A-IR800-SW targeted and brightly labeled CRC tumors, both in primary-tumor and liver-metastasis models. M5A-IR800-SW at 75 μg exhibited highly-specific tumor labeling in a primary-tumor orthotopic model with a median tumor-to-background ratio of 9.77 and in a liver-metastasis orthotopic model with a median tumor-to-background ratio of 7.23 at 96 h. The precise labeling of the liver metastasis was due to lack of hepatic accumulation of M5A-IR800-SW in the liver. CONCLUSIONS: M5A-IR800-SW provided bright and targeted NIR images of human CRC in orthotopic primary-tumor and liver-metastasis mouse models. The results of the present study suggest the clinical potential of M5A-IR800-SW for fluorescence-guided surgery including metastasectomies for CRC. The lack of hepatic NIR signal is of critical importance to allow for precise labeling of liver tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsAnimalsMiceHumansMice, NudeFluorescent DyesAntibodies, MonoclonalPolyethylene GlycolsCell Line, Tumor

Stichwörter der Autor:innen

CEAColorectal cancerFluorescence imagingLS174TLiver metastasisNude miceOrthotopic implantationPrimary tumor

Substanzen

Fluorescent DyesAntibodies, MonoclonalPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Surgery, School of Medicine, University of California San Diego, La Jolla, California; VA San Diego Healthcare System, La Jolla, California.
  • Department of Surgery, School of Medicine, University of California San Diego, La Jolla, California; School of Medicine, University of California San Diego, La Jolla, California.
  • Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California.
  • Department of Immunology and Theranostics, Beckman Research Institute, City of Hope, Duarte, California.
  • Department of Surgery, School of Medicine, University of California San Diego, La Jolla, California; VA San Diego Healthcare System, La Jolla, California; AntiCancer, Inc., San Diego, California.
  • Department of Surgery, School of Medicine, University of California San Diego, La Jolla, California; VA San Diego Healthcare System, La Jolla, California. Electronic address: mbouvet@ucsd.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Turner, M. A., Amirfakhri, S., Nishino, H., Neel, N. C., Hosseini, M., Cox, K. E., Lwin, T. M., Li, L., Hong, T., Sherman, A., Shively, J. E., Hoffman, R. M., Yazaki, P. J., & Bouvet, M. (2023). PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2023.06.013

Vancouver

Turner MA, Amirfakhri S, Nishino H, Neel NC, Hosseini M, Cox KE, et al. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models. Journal of Surgical Research. 2023. doi:10.1016/j.jss.2023.06.013

BibTeX
@article{Turner2023,
  author = {Turner, Michael A and Amirfakhri, Siamak and Nishino, Hiroto and Neel, Nicholas C and Hosseini, Mojgan and Cox, Kristin E and Lwin, Thinzar M and Li, Lin and Hong, Teresa and Sherman, Anakim and Shively, John E and Hoffman, Robert M and Yazaki, Paul J and Bouvet, Michael},
  title = {PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models},
  journal = {Journal of Surgical Research},
  year = {2023},
  doi = {10.1016/j.jss.2023.06.013}
}
Kostenlos starten →